MedPath

PADAGIS US LLC

PADAGIS US LLC logo
🇺🇸United States
Ownership
Holding
Employees
251
Market Cap
-
Website
http://www.padagis.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

49

FDA:49

Drug Approvals

Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide

Approval Date
Sep 23, 2025
FDA

Testosterone Cypionate

Approval Date
Mar 24, 2025
FDA

LIDOCAINE AND PRILOCAINE

Approval Date
Jul 31, 2024
FDA

hydromorphone hydrochloride

Approval Date
Jan 15, 2024
FDA

Methylphenidate Transdermal System

Approval Date
Nov 13, 2023
FDA

Cyclosporine

Approval Date
Oct 1, 2023
FDA

Paroxetine

Approval Date
Sep 1, 2023
FDA

SPIRONOLACTONE

Approval Date
Aug 31, 2023
FDA

Repaglinide

Approval Date
Aug 10, 2023
FDA

Belladonna and Opium

Approval Date
Aug 9, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.